You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方達控股(01521.HK)斥420萬加幣收購加拿大藥物合同研究機構
阿思達克 12-16 16:36

方達控股(01521.HK)公布,於今年12月13日,公司透過Frontage Laboratories, Inc.擁有的間接全資加拿大附屬11736655 CANADA LTD.與賣方J&J Corporate Services, Inc.訂立股份購買協議,11736655 CANADA LTD.同意以420萬元加幣購買目前由賣方持有的BRI全部流通在外股份。

目標公司BRI為其現任總裁及創辦人David Kwok所創立的合同研究機構,於加拿大溫哥華成立至今已逾20年。BRI從事為製藥及生物科技公司提供科學驅動的藥物發現及可提交研究性新藥/新藥申請之研究。公司認為,北美和中國的製藥行業外包預期將持續增長。收購事項能使公司運用現有優勢並擴大產能,以從製藥行業外包及對公司服務相關需求的預期增長中尋求機會。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account